Steven Cohen’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-102,399
| Closed | -$3.93M | – | 3001 |
|
|
2023
Q2 | $3.93M | Sell |
102,399
-629,770
| -86% | -$16.2M | 0.01% | 888 |
|
|
2023
Q1 | $16.9M | Sell |
732,169
-535,491
| -42% | -$12.8M | 0.05% | 403 |
|
|
2022
Q4 | $33.2M | Sell |
1,267,660
-1,173,094
| -48% | -$26M | 0.11% | 235 |
|
|
2022
Q3 | $48M | Buy |
2,440,754
+21,655
| +0.9% | +$434K | 0.19% | 141 |
|
|
2022
Q2 | $42.3M | Buy |
2,419,099
+1,164,899
| +93% | +$18.3M | 0.18% | 153 |
|
|
2022
Q1 | $20.5M | Sell |
1,254,200
-1,097,543
| -47% | -$14.9M | 0.08% | 319 |
|
|
2021
Q4 | $38.4M | Buy |
2,351,743
+1,356,873
| +136% | +$19.3M | 0.15% | 181 |
|
|
2021
Q3 | $12.7M | Sell |
994,870
-498,030
| -33% | -$6.56M | 0.06% | 434 |
|
|
2021
Q2 | $21.1M | Buy |
1,492,900
+322,702
| +28% | +$5.16M | 0.09% | 277 |
|
|
2021
Q1 | $18.2M | Buy |
1,170,198
+272,952
| +30% | +$4.45M | 0.09% | 282 |
|
|
2020
Q4 | $14.2M | Buy |
897,246
+487,246
| +119% | +$7.35M | 0.07% | 357 |
|
|
2020
Q3 | $4.98M | Buy |
+410,000
| New | +$5.5M | 0.03% | 561 |
|
|
2018
Q2 | – | Sell |
-340,000
| Closed | -$15.8M | – | 1235 |
|
|
2018
Q1 | $15.8M | Sell |
340,000
-113,352
| -25% | -$4.15M | 0.07% | 338 |
|
|
2017
Q4 | $17M | Buy |
453,352
+434,132
| +2,259% | +$19M | 0.07% | 332 |
|
|
2017
Q3 | $1.02M | Buy |
+19,220
| New | +$1.14M | ﹤0.01% | 741 |
|
|
2015
Q4 | – | Sell |
-169,140
| Closed | -$16.4M | – | 886 |
|
|
2015
Q3 | $16.4M | Buy |
169,140
+67,726
| +67% | +$8.07M | 0.13% | 224 |
|
|
2015
Q2 | $15.4M | Buy |
+101,414
| New | +$16.7M | 0.11% | 249 |
|
Steven Cohen's KDNY Position: Q3 2023 in Review
Steven Cohen sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 102,399 shares — an estimated $3.93M sold.
Steven Cohen first reported a position in KDNY in Q2 2015 and held it in 17 quarters. The position peaked at $48M in Q3 2022. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Steven Cohen reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Steven Cohen sold 102,399 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.93M.
- Steven Cohen first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
- Steven Cohen's Chinook Therapeutics, Inc. Common Stock position peaked at $48M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.